We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

20 hedge funds and large institutions have $672K invested in T2 Biosystems, Inc in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

296% more call options, than puts

Call options by funds: $111K | Put options by funds: $28K

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

63% less funds holding

Funds holding: 5420 (-34)

76% less capital invested

Capital invested by funds: $2.84M → $672K (-$2.17M)

92% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 37

Holders
20
Holders Change
-34
Holders Change %
-62.96%
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
7
Reduced
5
Closed
37
Calls
$111K
Puts
$28K
Net Calls
+$83K
Net Calls Change
+$71K

TTOO Hedge Fund Activity: Q4 2022 in Review

20 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q4 2022, worth a combined $672K — down 76% from $2.84M a quarter earlier.

Sellers outnumbered buyers: 37 funds closed out of TTOO and 3 opened new positions — a net loss of 34 holders — while 5 trimmed existing stakes and 7 added.

The largest buyer was McAdam LLC, adding an estimated $228K. The largest seller was Altium Capital Management, exiting entirely with an estimated $321K sold.

  • 20 institutional investors held T2 Biosystems, Inc (TTOO) as of Q4 2022, down from 54 in Q3 2022.
  • Funds reported $672K of T2 Biosystems, Inc stock for Q4 2022, down 76% quarter-over-quarter.
  • 3 funds opened new T2 Biosystems, Inc positions in Q4 2022 and 37 closed out, a net change of -34 holders.
  • The largest T2 Biosystems, Inc buyer in Q4 2022 was McAdam LLC, an estimated $228K added.
  • The largest T2 Biosystems, Inc seller in Q4 2022 was Altium Capital Management, an estimated $321K sold.

Based on aggregated 13F filings for Q4 2022.